MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517017597 A) filed by Kinki University, Osaka, Japan, on Feb. 27, for 'pharmaceutical compositions for the treatment of allergic diseases.'
Inventor(s) include Nishida Shozo; Tsubaki Masanobu; Takeda Tomoya; Tanabe Genzoh; Takashima Katsuki; and Morikawa Toshio.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "Antibody preparations for treating allergic diseases have been proposed. However, the route of administration of the antibody preparations is limited to an intravenous route, which imposes a burden on patients. Furthermore, novel drugs that inhibit kinases such as NIK are still needed for the development of effective pharmaceuticals and the like for treating allergic diseases. At least one compound selected from mangiferin 8a having a xanthone backbone (formula (1)), norathyriol (formula (2)), mangiferin (formula (3)), 1,3,5,6-tetrahydroxyxanthone (formula (4)), xanthydrol (formula (5)), a-mangostin (formula (6)) and ?-mangostin (formula (7)) can ameliorate allergic diseases and can exhibit the effect thereof through oral ingestion."
The patent application was internationally filed on Aug. 01, 2023, under International application No.PCT/JP2023/028116.
Disclaimer: Curated by HT Syndication.
